Usefulness of amlodipine for angina pectoris

https://doi.org/10.1016/0002-9149(94)90271-2Get rights and content

Abstract

Calcium antagonists are effective antianginal agents in the treatment of patients with stable exercise-induced angina pectoris. A series of randomized, double-blind, placebo-controlled studies with the novel, once-daily calcium antagonist amlodipine have been completed in a large number of patients with stable exercise-induced angina pectoris. Compared with placebo, once-daily amlodipine demonstrated a significant dose-related extension in exercise duration and workload accomplished, and reduction in number of anginal attacks and associated glyceryl trinitrate consumption. The clinical antianginal attributes of amlodipine were accompanied by significant reductions in electrocardiographic evidence of myocardial ischemia. In comparison with other antianginal drugs, once-daily amlodipine at a dosage range of 5–10 mg demonstrated antianginal activity comparable to thrice-daily diltiazem and once-daily nadolol. Amlodipine administered once daily achieves symptomatic and electrocardiographic amelioration of myocardial ischemic episodes induced by exercise in the majority of patients with stable angina pectoris. Amlodipine does not depress left ventricular pumping activity, and its side-effect profile does not differ substantially from that of placebo.

Cited by (43)

  • Refractory Angina

    2018, Chronic Coronary Artery Disease: A Companion to Braunwald's Heart Disease
  • Refractory Angina

    2017, Chronic Coronary Artery Disease: A Companion to Braunwald's Heart Disease
  • Post-valvular surgery multi-vessel coronary artery spasm - A literature review

    2016, IJC Heart and Vasculature
    Citation Excerpt :

    Optimal therapeutic strategy for postoperative CAS continues to evolve. Currently, the therapeutic agents of choice with demonstrated efficacy for CAS are long-acting nitrates and calcium channel blockers [2–4,40–42]. Of the 11 post-valvular surgery CAS reports reviewed, only in 2 reports were nitrates and/or calcium pump blockers found to be ineffective (Table 1).

  • Adjunctive pharmacologic therapies in acute myocardial infarction

    2010, Cardiac Intensive Care: Expert Consult
View all citing articles on Scopus
View full text